Go Deep
Fermenta Biotech Limited
Fermenta Biotech Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 23,172 | 23.5 | 3.38 | 0.28 | 479.30 |
| Sep 2026 | 23,631 | 23.5 | 3.38 | 0.28 | 479.30 |
| Oct 2026 | 22,082 | 26.9 | 3.90 | 0.28 | 553.25 |
| Oct 2026 | 21,846 | 25.0 | 3.65 | 0.28 | 517.55 |
Fermenta Biotech Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,218,212,000.0 | 1,215,834,000.0 | 1,373,606,000.0 | 1,302,227,000.0 |
| Net Profit | 97,381,000.0 | 191,899,000.0 | 126,801,000.0 | 188,781,000.0 |
| EPS | 3.4 | 6.7 | 4.4 | 6.5 |
Fermenta Biotech Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 5,235,555,000.0 | 4,670,939,000.0 | 3,334,625,000.0 | 3,490,553,000.0 |
| Net Profit | 717,653,000.0 | 768,618,000.0 | -230,598,000.0 | -510,752,000.0 |
| EPS | 24.7 | 26.4 | -8.0 | -17.7 |
Fermenta Biotech Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 6,479,390,000.0 | 6,144,753,000.0 | 5,478,308,000.0 | 6,365,157,000.0 | — |
| Total Liabilities | 2,473,931,000.0 | 2,559,600,000.0 | 2,626,677,000.0 | 3,239,509,000.0 | — |
| Total Equity | 4,062,138,000.0 | 3,626,722,000.0 | 2,888,610,000.0 | 3,153,138,000.0 | — |
Owes vs Owns
Fermenta Biotech Limited owed ₹0.38 for every ₹1 it owned in Mar 2026, down from ₹0.51 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.38× | 0.42× | 0.48× | 0.51× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Fermenta Biotech Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 12.8%Receivables 17.2%Inventory 23.5%Fixed assets (tangible) 34.6%Intangible assets 1.0%Other assets 10.8%
How it's funded — Mar 2026
Short-term debt 15.6%Long-term debt 1.2%Payables 8.6%Other liabilities 12.7%Shareholders' equity 61.8%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 83.0 | 70.7 | 59.8 | 60.1 |
| Receivables | 111.6 | 95.2 | 69.8 | 41.6 |
| Inventory | 152.5 | 123.7 | 87.4 | 130.1 |
| Fixed assets (tangible) | 224.0 | 232.3 | 253.7 | 259.5 |
| Intangible assets | 6.7 | 7.1 | 11.3 | 24.8 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 70.0 | 85.5 | 65.8 | 120.4 |
| Liabilities & equity | ||||
| Short-term debt | 101.0 | 94.4 | 89.7 | 133.3 |
| Long-term debt | 7.9 | 15.0 | 42.5 | 83.6 |
| Payables | 56.0 | 60.1 | 64.9 | 45.8 |
| Other liabilities | 82.5 | 86.5 | 65.5 | 61.3 |
| Shareholders' equity | 400.5 | 358.5 | 285.2 | 312.6 |
| Net tangible assets | 399.5 | 355.6 | 277.6 | 290.5 |
Fermenta Biotech Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 928,337,000.0 | 409,020,000.0 | 1,053,459,000.0 | 1,161,083,000.0 | — |
| Investing Activities | -429,963,000.0 | -1,595,000.0 | -154,974,000.0 | -554,085,000.0 | — |
| Financing Activities | -422,886,000.0 | -508,658,000.0 | -908,518,000.0 | -413,799,000.0 | — |